SRX1007807 M.fluviatilis-FB SRP057622 Total RNA from whole brain was purified using the RNeasy® Lipid Tissue Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920684 FB RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000 SRX1007829 M.fluviatilis-FG SRP057622 Total RNA was purified from approximately 15 mg ovary tissue using the RNeasy® Mini Kit (QIAGEN Pty. Ltd., Australia). Total RNA from whole brain was purified using the RNeasy® Lipid Tissue Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920704 FG RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000 SRX1007830 M.fluviatilis-FL SRP057622 Total RNA was purified from approximately 15 mg liver tissue using the RNeasy® Mini Kit (QIAGEN Pty. Ltd., Australia). Total RNA from whole brain was purified using the RNeasy® Lipid Tissue Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920705 SAMN03566738 FL RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000 SRX1007831 M.fluviatilis-MB SRP057622 Total RNA from whole brain was purified using the RNeasy® Lipid Tissue Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920706 MB RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000 SRX1007832 M.fluviatilis-MG SRP057622 Total RNA was purified from approximately 15 mg ovary tissue using the RNeasy® Mini Kit (QIAGEN Pty. Ltd., Australia). Total RNA from whole brain was purified using the RNeasy® Lipid Tissue Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920707 SAMN03566740 MG RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000 SRX1007833 M.fluviatilis-ML SRP057622 Total RNA was purified from approximately 15 mg liver tissue using the RNeasy® Mini Kit (QIAGEN Pty. Ltd., Australia). On-column DNase treatments were included during purification. RNA integrity was confirmed using the Bioanalzyer 2100 (Agilent). Sequencing was undertaken by a service provider (Australian Genome Research Facility, Melbourne, Australia). Library preparation was performed using Illumina TruSeq reagents and sequencing was conducted using the HiSeq2000 platform. Briefly, RNA quality was determined using a Bioanalyzer 2100 (Agilent) before isolation of polyA+ mRNA, fragmentation, and construction of cDNA libraries using the Illumina TruSeq kit according to the standard protocol. 100-cycle paired-end sequencing was undertaken using two lanes of an Illumina HiSeq2000 instrument, with three libraries multiplexed per lane. SRS920708 ML RNA-Seq TRANSCRIPTOMIC PolyA 200 0 Application Read Forward 1 1 Application Read Reverse 101 Illumina HiSeq 2000